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Electronic alerts to prevent venous thromboembolism among hospital-
ized patients
Kucher N, Koo S, Quiroz R, et al. N Engl J Med 2005;352:969-77.
Conclusion: A computer-based program to alert physicians regarding
the use of venous thromboembolism (VTE) prophylaxis markedly reduced
rates of pulmonary embolism and deep venous thrombosis (DVT) in hospi-
talized patients at risk for VTE.
Summary: The authors hypothesized that use of a computer alert
program to alert physicians regarding hospitalized patients at high risk for
VTE might reduce the frequency of DVT by increasing the frequency of
prophylaxis. A computer program was developed linked to a patient database
to identify hospitalized patients at risk for VTE. The patients were randomly
assigned to an intervention group in which the treating physician was made
aware of the patient’s risk of VTE (n 1255) or to a control group in which
no such alert was issued (n  1251). Physicians receiving the alert for VTE
prophylaxis were required to acknowledge the alert and could then order or
withhold prophylaxis according to clinical judgment. Prophylaxis included
graduated compression stockings, pneumatic compression boots, unfrac-
tionated heparin, warfarin, or low-molecular-weight heparin. Clinically di-
agnosed, objectively confirmed VTE (DVT or pulmonary embolism) at 90
days was the primary end point.
There was a greater use of mechanical prophylaxis in the intervention
group (10.0% vs 1.5%; P  .001) and a greater use of pharmacologic
prophylaxis in the intervention group (23.6% vs 13.0%; P  .001). There
were 103 (8.2%) primary end points in the control group and 61 (4.9%) end
points in the intervention group. Freedom from VTE at 90 days was 94.1%
(95% CI, 92.5%-95.5%) in the intervention group vs 90.6% (95% CI,
88.7%-92.2%; P  .001) in the control group. The risk of VTE at 90 days
was reduced by 41% with the computer alert system (hazard ratio, 0.59; 95%
CI, 0.43-0.81; P  .001).
Comment:The necessity of VTE prophylaxis in hospitalized patients is
widely acknowledged, yet VTE prophylaxis is underused. This study indi-
cates that VTE prophylaxis can be increased and clinically evident VTE
events decreased through use of a physician alert system that notifies
physicians as to the patient’s VTE risk. Despite this, it is also clear that
because only 33.5% of patients in the intervention group received prophy-
laxis, additional measures will be required to maximize VTE prophylaxis in
hospitalized patients.
Statins decrease perioperative cardiac complications in patients under-
going non-cardiac vascular surgery
The Statins for Risk Reduction in Surgery (StaRRS) Study. J Am Coll
Cardiol 2005;45:336-42
Conclusion: Statins are highly protective against perioperative cardiac
complications in patients undergoing vascular surgery.
Summary: The authors sought to assess whether statins can decrease
cardiac complications in patients undergoing noncardiac vascular surgery.
This was a retrospective study that recorded patient history, admission
medications, and other patient characteristics in patients undergoing carotid
endarterectomy, lower extremity revascularization, or abdominal aortic an-
eurysm repair from January 1999 to December 2000. Data were derived
from a tertiary medical center. Perioperative complications of death, myo-
cardial ischemia, myocardial infarction, congestive heart failure, and ventric-
ular tachyarrhythmias were recorded. Predictors of perioperative cardiac
complications and potential medications that may confer a protective benefit
for perioperative cardiac complications were analyzed by using univariate
and multivariate logistic regression analysis. There were 157 complications
in 1163 eligible hospitalizations. There were significantly fewer complica-
tions in patients receiving statins (9.9%) than in those not receiving statins
(16.5%; P  .001). The difference between the two groups was mostly due
to the occurrence of congestive heart failure and myocardial ischemia.
Adjustment for significant predictors of perioperative complications such as
age, sex, type of operation, previously known left ventricular dysfunction,
and diabetes still resulted in statins conferring a highly significant protective
effect (odds ratio, 0.52; P  .001).
Comment: It is now well appreciated that statins have significant
pleotrophic effects in addition to decreasing lipid levels. This article does
not indicate when statins need to be started before an operation or how
long they need to be continued after an operation. If vascular surgeons
are going to prescribe statins to reduce perioperative complications, they
must then be prepared to monitor the drugs’ potential side effects and
complications. Alternatively, they must communicate with primary care
physicians to ensure that the medications are properly used and the
patients adequately followed up.
Prospective randomised study of Endovenous Radiofrequency Oblit-
eration (Closure) Versus Ligation and Vein Stripping (EVOLVeS):
2-year follow-up
Lurie F, Creton D, Eklof B, et al. Eur J Vasc Endovasc Surg 2005;29:67-73.
Conclusion: At 2 years, closure of the greater saphenous vein (GSV)
with radiofrequency obliteration provides results at least equal to those of
high ligation and stripping of the GSV.
Summary: EVOLVeS is a small, prospective, randomized study that
compared radiofrequency obliteration of the GSV with high ligation and
stripping of the GSV in patients with symptomatic varicose veins or GSV
incompetence and who were candidates for either conventional vein strip-
ping or radiofrequency obliteration of the GSV. There were five participat-
ing sites: two in France, one in Austria, and two in the United States. A total
of 85 patients were entered into the study, with 46 limbs allocated to
radiofrequency obliteration and 40 limbs to high ligation and stripping.
Eighty limbs received treatment. This article reports intermediate clinical
outcomes, rates of recurrent varicosities and neovascularization, follow-up
ultrasound changes of the GSV, and quality-of-life changes in the patients
participating in the trial. There were 45 patients re-examined at 1 year and
65 patients re-examined 2 years after treatment. At follow-up, patients were
classified with regard to the CEAP classification for chronic venous disease
and had calculation of venous clinical severity scores. Ultra sound examina-
tions and quality-of-life assessments were also performed. There were no
differences in the CEAP classifications or venous clinical severity scores in the
two groups at 1 and 2 years. Of the GSV trunks occluded by radiofrequency
ablation, 51% underwent progressive shrinkage of the GSV diameter over 2
years. An additional 41% of the GSVs became undetectable by ultrasound at
the 2-year follow-up. Two patients with initially closed GSVs by the closure
technique had reopening of the vein. Neovascularization was found in one
radiofrequency obliteration case and in four stripping and ligation cases. At
1 and 2 years of follow-up, there was a cumulative rate of recurrence of
varicose veins of 14% in the radiofrequency obliteration group and 21% in
the stripping and ligation group (not significant). Global quality-of-life
scores were in favor of radiofrequency ablation at 1 and 2 years after
treatment. Pain was the only quality-of-life variable consistently reduced in
the radiofrequency group.
Comment: This is another piece of evidence suggesting that, at least in
the short term, catheter-based interventions for obliteration of the GSV are
at least as effective as traditional ligation and stripping procedures. There are
still details to be worked out regarding catheter-based obliterations of the
GSV, such as the long-term effects of preservation of the proximal greater
saphenous branches and when and if to combine stab phlebectomy or
sclerotherapy with catheter-based treatment of the GSV.
Increased growth rate of abdominal aortic aneurysms in women, the
Tromso Study
Solberg S, Singh K, Wilsgaard T, et al. Eur J Vasc Endovasc Surg 2005;29:
145-9.
Conclusion: Female sex is an independent predictor for increased
growth rate of an abdominal aortic aneurysm (AAA).
Summary: The Tromso Study is a population-based study emphasiz-
ing cardiovascular disease. It began in 1974. In this component of the study,
men and women age 55 to 74 years were eligible for examination of their
abdominal aorta with ultrasound. An AAA was considered to be present if
the abdominal aorta was greater than 3.5 cm in diameter, there was a
localized dilatation of the infrarenal aorta, or there was a 5-mm increase of
the infrarenal abdominal aorta compared with the diameter of the aorta at
the level of the renal arteries. If these criteria were met, then the patient was
referred to have a CT scan of the abdominal aorta. Patients underwent
surgery for an abdominal aortic diameter of 5.5 cm or more. There were 348
patients identified with AAA. Fourteen did not attend CT scan follow-up,
and 31 were initially operated on because of the size of the aneurysm.
Forty-seven additional patients were believed as a result of CT scanning to
have a nonaneurysmal aorta. An additional 22 patients were lost to follow-
up. There were therefore 185 men and 49 women eligible for follow-up.
These subjects were followed up with ultrasound examination of the aorta
every 3 to 6 months from the beginning of this study in 1994/1995 to study
completion on December 31, 2002. During follow-up, 49 patients under-
went operation because of aneurysm growth, and 48 patients died without
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